 The study is being funded over a three year period. The first year involves the set up and development of the protocol and the recruitment of the control participants. It is hoped that the recruitment of the patients will start nine months into the study period and will take 25 months to complete the data collection and analysis. This will allow two months for the reporting of the study. 